Can we predict who recovers best from radical cancer surgery?
NCT ID NCT00791635
First seen Jun 27, 2026 · Last updated Sep 15, 2026 · Updated 2 times
Summary
This study follows women who have had pelvic exenteration—a surgery removing the lower colon, rectum, and bladder—for gynecologic cancers like cervical or endometrial cancer. Researchers want to see if factors like tumor size or surgery type affect complications, quality of life, and survival. By analyzing past and current patients, they hope to find patterns that improve future care.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this could help doctors predict which patients recover best from this major surgery and improve post-surgical care.
- What could go wrong
- This is an observational study, not testing a new treatment. It may not lead to direct changes in care, and results depend on a small, specific group of patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
79 people
The number who actually took part.
- Started
-
Jul 2008
- Expected to finish
-
Sep 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Women with a history of gynecologic malignancy who have undergone or are being offered a pelvic exenteration
- Ages
-
18 years and older
- Sex
-
Female participants only
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Women with a history of gynecologic malignancy, including cervical, endometrial, vulvar, or vaginal carcinoma of any histology * Women who have undergone a pelvic exenteration after January 1993 or who are being offered a pelvic exenteration for treatment of their gynecologic malignancy * Patients must be suitable candidates for surgery (in case of prospective collection) * Patients who have signed an approved informed consent * Patients with a prior malignancy allowed if \> 3 years previous with no current evidence of disease * Women must be able to read and write in either Spanish or English Exclusion Criteria: * Patients with contraindications to surgery * Patients unwilling or unable to complete self-administered questionnaires * Patients who do not read or speak English or Spanish
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Cervical carcinoma are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
M D Anderson Cancer Center
Houston, Texas, 77030, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Blood test aims to catch Cancer's return earlier
- Can fewer, stronger radiation doses spare the bowel in gynecologic cancers?
- Can one surgery treat endometrial cancer and obesity together?
- A chill pill for Chemo's side effects? cooling therapy and a Blood-Flow drug take on nerve pain
- Why is endometrial cancer often advanced in brazil? a new study digs into the data
- Wearable tech could spot Post-Surgery problems early